Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Medipharm Labs Corp (TSX: LABS ) 0.0750 UNCHANGED Streaming Delayed Price Updated: 3:59 PM EDT, Jun 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.0750 Bid (Size) 0.0750 (9,840) Ask (Size) 0.0750 (140) Prev. Close 0.0750 Today's Range 0.0750 - 0.0750 52wk Range 0.0550 - 0.1000 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position' May 15, 2024 Via Benzinga This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses March 27, 2024 Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,... Via Benzinga Performance YTD +15.38% +15.38% 1 Month -6.25% -6.25% 3 Month +15.38% +15.38% 6 Month +15.38% +15.38% 1 Year +15.38% +15.38% More News Read More Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil February 07, 2024 Via Benzinga Topics Cannabis Exposures Cannabis Product Safety Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024 December 22, 2023 Via Benzinga Topics Cannabis Exposures Cannabis MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report November 14, 2023 Via Benzinga MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M October 02, 2023 Via Benzinga MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next September 20, 2023 Via Benzinga MediPharm Labs Corp. to Acquire VIVO Cannabis Inc. December 22, 2022 Via Newsfile Topics Cannabis Exposures Cannabis MediPharm Labs Sees 16.5% QoQ Increase In International Medical Cannabis Sales, Announces New CEO November 15, 2021 Via Benzinga Topics Cannabis Exposures Cannabis MediPharm Labs Taps Bryan Howcroft as Chief Executive Officer And Director October 21, 2021 Via Benzinga MediPharm Labs To Provide Materials For Clinical Trial On CBD For Insomnia August 31, 2021 Via Benzinga MediPharm Labs Reports 24% QoQ Pop In International Sales, Q2 2021 Revenue Drops 63.6% YoY August 16, 2021 Via Benzinga MediPharm Labs Receives Canadian GMP Pharmaceutical Drug Establishment License July 14, 2021 Via Benzinga Another Near Billion-Dollar Cannabis Acquisition Signals More Hyper Valuations to Come July 09, 2021 Via FinancialNewsMedia Topics Cannabis Exposures Cannabis MediPharm Labs Extends Collaboration With German Medical Cannabis Distributor ADREXpharma June 08, 2021 Via Benzinga Topics Cannabis Exposures Cannabis MediPharm Posts Q1 2021 Results: What Cannabis Stock Investors Need To Know May 17, 2021 Via Benzinga Topics Cannabis Exposures Cannabis Number Of Cannabis Patents Granted In Europe & UK Growing At A Quick Pace April 29, 2021 Via FinancialNewsMedia Topics Cannabis Intellectual Property Law Enforcement Exposures Cannabis Intellectual Property Legal Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market April 13, 2021 From IM Cannabis Corp. Via AccessWire Topics Cannabis Law Enforcement Exposures COVID-19 Cannabis Legal Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
